구강 창상 피복재 시장 규모, 점유율 및 동향 분석 보고서 : 제품 유형별, 소재별, 용도별, 최종 용도별, 유통 채널별 및 지역별 부문의 예측(2026-2033년)

Oral Wound Dressing Market Summary

The global oral wound dressing market size was valued at USD 2.5 billion in 2025 and is projected to grow from USD 2.8 billion in 2026 to USD 5.3 billion by 2033, growing at a CAGR of 9.7% from 2026 to 2033. North America dominated the oral wound dressing industry, accounting for the largest revenue share of 40.20% in 2025. The market is primarily driven by the increasing prevalence of oral ulcers, periodontal diseases, and oral mucositis associated with cancer therapies.

Rising volumes of dental implant procedures, tooth extractions, and other oral surgeries are creating greater demand for products that accelerate healing and reduce post-operative complications. In addition, advancements in bioadhesive hydrogels, collagen-based dressings, and antimicrobial wound care technologies are improving clinical outcomes and supporting wider adoption across hospitals and dental clinics.

The growing global burden of oral diseases, affecting approximately 3.7 billion people worldwide, is increasing the number of patients requiring treatment for oral ulcers, periodontal conditions, and surgical wounds. This expanding patient population is driving demand for oral wound dressings that promote faster healing, reduce pain, and protect oral tissues from infection and further injury.

The rising incidence of oral cancer is a significant market driver, as patients frequently undergo surgical resections, radiation therapy, and chemotherapy that result in painful oral wounds and mucosal damage. These treatments increase the need for advanced wound dressings that can protect tissues, reduce pain, prevent infection, and accelerate healing. In addition, the growing number of oral cancer cases worldwide is driving demand for bioadhesive, antimicrobial, and regenerative oral wound care products across hospitals and oncology centers.

Global Oral Wound Dressing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global oral wound dressing market report based on product, material, application, end user, distribution channel, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Mucoadhesive Patches & Films
• Bioadhesive Gels
• Oral Rinses / Mouthwashes
• Oral Sprays
• Periodontal Dressings & Surgical Pastes
• Resorbable Matrices & Scaffolds
• Material Type Outlook (Revenue, USD Billion, 2021 - 2033)
• Natural Biopolymer-Based
• Synthetic Polymer-Based
• Hybrid / Composite Material
• Application Outlook (Revenue, USD Billion, 2021 - 2033)
• Surgical Wounds
• Inflammatory & Ulcerative Lesions
• Traumatic Lesions
• Regenerative Procedures
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Dental Clinics & Group Practices
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Oral Surgery Centers
• Home Care Settings
• Distribution Channel Outlook (Revenue, USD Million; 2021 - 2033)
• Direct Institutional Sales
  • Dental Service Organizations (DSOs)
  • Large Hospital Networks
  • Group Purchasing Organizations (GPOs)
• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Dental Distributors
• E-commerce / Online Pharmacies
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Material Type
  • 1.1.3. Application
  • 1.1.4. End Use
  • 1.1.5. Distribution Channel
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Oral Wound Dressing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of oral diseases
    • 3.2.1.2. Growth in dental procedures and implant surgeries
    • 3.2.1.3. Increasing oral cancer and cancer therapy-related mucositis
    • 3.2.1.4. Advancements in bioadhesive and regenerative technologies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High Cost of advanced oral wound dressings
    • 3.2.2.2. Limited reimbursement coverage
    • 3.2.2.3. Availability of alternative treatments
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Development of drug-eluting oral dressings
    • 3.2.3.2. Expansion in emerging markets
    • 3.2.3.3. Increasing adoption of personalized and regenerative medicine
    • 3.2.3.4. Growing geriatric population
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Difficulty in maintaining dressing retention in the oral cavity
    • 3.2.4.2. Regulatory and clinical validation requirements
• 3.3. Oral Wound Dressing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Oral Wound Dressing Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Oral Wound Dressing Market Product Movement Analysis
• 4.3. Global Oral Wound Dressing Market Size & Trend Analysis, by Product, 2021 to 2035 (USD Billion)
• 4.4. Mucoadhesive Patches & Films
  • 4.4.1. Mucoadhesive patches & films market estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.5. Bioadhesive Gels
  • 4.5.1. Bioadhesive Gels market estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.6. Oral Rinses/Mouthwashes
  • 4.6.1. Oral rinses/mouthwashes market estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.7. Oral Sprays
  • 4.7.1. Oral Sprays market estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.8. Periodontal Dressings & Surgical Pastes
  • 4.8.1. Periodontal dressings & surgical pastes market estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.9. Resorbable Matrices & Scaffolds
  • 4.9.1. Resorbable matrices & scaffolds market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Oral Wound Dressing Market: Material Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Oral Wound Dressing Market Material Type Movement Analysis
• 5.3. Global Oral Wound Dressing Market Size & Trend Analysis, by Material Type, 2021 to 2035 (USD Billion)
• 5.4. Natural Biopolymer-Based
  • 5.4.1. Natural biopolymer-based market estimates and forecasts, 2021 - 2033 (USD Billion)
• 5.5. Synthetic Polymer-Based
  • 5.5.1. Synthetic polymer-based market estimates and forecasts, 2021 - 2033 (USD Billion)
• 5.6. Hybrid / Composite Material
  • 5.6.1. Hybrid/composite material market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Oral Wound Dressing Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Oral Wound Dressing Market Application Movement Analysis
• 6.3. Global Oral Wound Dressing Market Size & Trend Analysis, by Application, 2021 to 2035 (USD Billion)
• 6.4. Surgical Wounds
  • 6.4.1. Surgical wounds market estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.5. Inflammatory & Ulcerative Lesions
  • 6.5.1. Inflammatory & ulcerative lesions market estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.6. Traumatic Lesions
  • 6.6.1. Traumatic lesions market estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.7. Regenerative Procedures
  • 6.7.1. Regenerative Procedures market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Oral Wound Dressing Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Oral Wound Dressing Market End Use Movement Analysis
• 7.3. Global Oral Wound Dressing Market Size & Trend Analysis, by End Use, 2021 to 2035 (USD Billion)
• 7.4. Dental Clinics & Group Practices
  • 7.4.1. Dental clinics & group practices market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.5. Hospitals
  • 7.5.1. Hospitals market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.6. Ambulatory Surgical Centers (ASCs)
  • 7.6.1. Ambulatory Surgical Centers (ASCs) market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.7. Specialty Oral Surgery Centers
  • 7.7.1. Specialty oral surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.8. Homecare Settings
  • 7.8.1. Homecare settings market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Oral Wound Dressing Market: Distribution Channel Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Oral Wound Dressing Market End Use Movement Analysis
• 8.3. Global Oral Wound Dressing Market Size & Trend Analysis, by End Use, 2021 to 2035 (USD Billion)
• 8.4. Direct Institutional Sales
  • 8.4.1. Direct institutional sales market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 8.4.2. Dental Service Organizations (DSOs)
  • 8.4.3. Dental service organizations (DSOs) market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 8.4.4. Large Hospital Networks
  • 8.4.5. Large hospital networks market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 8.4.6. Group Purchasing Organizations (GPOs)
  • 8.4.7. Group purchasing organizations (GPOs) market estimates and forecasts, 2021 - 2033 (USD Billion)
• 8.5. Hospital Pharmacies
  • 8.5.1. Hospital pharmacies market estimates and forecasts, 2021 - 2033 (USD Billion)
• 8.6. Retail Pharmacies & Drug Stores
  • 8.6.1. Retail pharmacies & drug stores market estimates and forecasts, 2021 - 2033 (USD Billion)
• 8.7. Dental Distributors
  • 8.7.1. Dental distributors market estimates and forecasts, 2021 - 2033 (USD Billion)
• 8.8. E-commerce / Online Pharmacies
  • 8.8.1. E-commerce / online pharmacies market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Oral Wound Dressing Market: Regional Estimates & Trend Analysis by Product Type, Material Type, Application, End Use, and Distribution Channel

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2035
• 9.3. North America
  • 9.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Competitive scenario
    • 9.3.2.3. Regulatory framework
    • 9.3.2.4. Reimbursement scenario
    • 9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Competitive scenario
    • 9.3.3.3. Regulatory framework
    • 9.3.3.4. Reimbursement scenario
    • 9.3.3.5. Canada market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Competitive scenario
    • 9.3.4.3. Regulatory framework
    • 9.3.4.4. Reimbursement scenario
    • 9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Competitive scenario
    • 9.4.1.3. Regulatory framework
    • 9.4.1.4. Reimbursement scenario
    • 9.4.1.5. UK market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. Reimbursement scenario
    • 9.4.2.5. Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Reimbursement scenario
    • 9.4.3.5. France market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Reimbursement scenario
    • 9.4.4.5. Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory framework
    • 9.4.5.4. Reimbursement scenario
    • 9.4.5.5. Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.6. Denmark
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory framework
    • 9.4.6.4. Reimbursement scenario
    • 9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Competitive scenario
    • 9.4.7.3. Regulatory framework
    • 9.4.7.4. Reimbursement scenario
    • 9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.8. Norway
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Competitive scenario
    • 9.4.8.3. Regulatory framework
    • 9.4.8.4. Reimbursement scenario
    • 9.4.8.5. Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Competitive scenario
    • 9.5.1.3. Regulatory framework
    • 9.5.1.4. Reimbursement scenario
    • 9.5.1.5. Japan market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.2. India
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. India market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.3. China
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. China market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.4. South Korea
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.5. Australia
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Reimbursement scenario
    • 9.5.5.5. Australia market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Reimbursement scenario
    • 9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Competitive scenario
    • 9.6.1.3. Regulatory framework
    • 9.6.1.4. Reimbursement scenario
    • 9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Competitive scenario
    • 9.7.1.3. Regulatory framework
    • 9.7.1.4. Reimbursement scenario
    • 9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. UAE market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
  • 10.2.1. Innovators
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors and channel partners
  • 10.3.2. Key customers
  • 10.3.3. TBM Co.
    • 10.3.3.1. Company overview
    • 10.3.3.2. Financial performance
    • 10.3.3.3. Product benchmarking
    • 10.3.3.4. Strategic initiatives
  • 10.3.4. AD Surgical.
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. SUNSTAR Suisse S.A.
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. PULPDENT
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. Septodont Holding
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Ethicon Inc. (Johnson & Johnson)
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. ZimVie Inc.
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Ricerfarma s.r.l.
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. BIOINICIA
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Product benchmarking
    • 10.3.11.4. Strategic initiatives
  • 10.3.12. Jiangsu Yenssen Biotech Co.
    • 10.3.12.1. Company overview
    • 10.3.12.2. Financial performance
    • 10.3.12.3. Product benchmarking
    • 10.3.12.4. Strategic initiatives
  • 10.3.13. Hager Worldwide
    • 10.3.13.1. Company overview
    • 10.3.13.2. Financial performance
    • 10.3.13.3. Product benchmarking
    • 10.3.13.4. Strategic initiatives
• 10.4. Estimated Company Market Share Analysis, 2025
• 10.5. List of Other Key Market Players